Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by B. D. Lehmann
Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers After Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
Cancer Discovery
Oncology
Identification of Prognosis-Relevant Subgroups in Patients With Chemoresistant Triple-Negative Breast Cancer
Clinical Cancer Research
Cancer Research
Oncology
Related publications
Profiling Molecular Regulators of Recurrence in Chemorefractory Triple-Negative Breast Cancers
Breast Cancer Research
Cancer Research
Oncology
Molecular Stratification of Triple-Negative Breast Cancers
Oncologist
Cancer Research
Medicine
Oncology
Hyperactivated mTOR and JAK2/STAT3 Pathways: Molecular Drivers and Potential Therapeutic Targets of Inflammatory and Invasive Ductal Breast Cancers After Neoadjuvant Chemotherapy
Clinical Breast Cancer
Cancer Research
Oncology
Impact of Molecular Subtype Conversion of Breast Cancers After Neoadjuvant Chemotherapy on Clinical Outcome
Cancer Research and Treatment
Cancer Research
Oncology
Identification of Novel Therapeutic Targets for Triple-Negative Breast Cancer
Comparative Analysis of Different Neoadjuvant Chemotherapy Regimens for Triple-Negative Breast Cancer
Tumors of female reproductive system
Targeted-Gene Sequencing to Catch Triple Negative Breast Cancer Heterogeneity Before and After Neoadjuvant Chemotherapy
Cancers
Cancer Research
Oncology
Expanded Molecular Profiling of Myxofibrosarcoma Reveals Potentially Actionable Targets
Modern Pathology
Forensic Medicine
Pathology
Genetic Variations in Triple-Negative Breast Cancers Undergoing Neo-Adjuvant Chemotherapy